# A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

> **NCT01875003** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 348 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Lebrikizumab
- **DRUG:** Placebo
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT01875003
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-31
- **Primary completion:** 2016-12-28
- **Final completion:** 2016-12-28
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875003, "A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01875003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*